Article Versions Notes

Wu J, Xiao Z, Li H, Zhu N, Gu J, Wang W, Liu C, Wang W, Qin L. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer. Cancers. 2022; 14(14):3487. https://doi.org/10.3390/cancers14143487

Wu, Jiajun, Zuowei Xiao, Hongfang Li, Neng Zhu, Jia Gu, Wenmao Wang, Chao Liu, Wei Wang, and Li Qin. 2022. "Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer" Cancers 14, no. 14: 3487. https://doi.org/10.3390/cancers14143487

Wu, J., Xiao, Z., Li, H., Zhu, N., Gu, J., Wang, W., Liu, C., Wang, W., & Qin, L. (2022). Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer. Cancers, 14(14), 3487. https://doi.org/10.3390/cancers14143487